Global Disposable Enteral Syringes Market Size By Type (1 ml, 3 ml), By Application (Hospitals, Clinics), By Region, And Segment Forecasts, 2023 to 2032

The Global Disposable Enteral Syringes Market was valued at USD 0.74 billion in 2023 and is projected to reach USD 1.31 billion by 2031, growing at a CAGR of 7.3% during the forecast period from 2023 to 2031. Disposable enteral syringes are crucial for delivering medication and nutrition to patients who cannot ingest orally, especially in neonatal and critical care settings. The rising incidence of chronic illnesses, increasing neonatal admissions, and growing adoption of enteral feeding in home care environments are significant drivers of market growth.

Drivers:

1. Rising Prevalence of Chronic Illnesses and Premature Births:

An increase in chronic diseases such as cancer, neurological disorders, and gastrointestinal conditions has fueled the demand for enteral nutrition. Additionally, the global rise in premature births requires specialized feeding tools like enteral syringes, further propelling market growth.

2. Growth of Home Healthcare and Geriatric Population:

With healthcare shifting toward outpatient and home-based care models, the need for disposable and easy-to-use enteral syringes is rising. An aging global population also contributes to long-term nutritional therapy demand, expanding the market scope.

3. Infection Control Awareness:

Disposable enteral syringes minimize cross-contamination risks, particularly in ICUs and NICUs. Increased awareness of infection control practices post-COVID-19 is encouraging their widespread use across healthcare facilities.

Restraints:

1. Environmental Concerns and Plastic Waste Regulations:

Disposable syringes, largely made from plastic, contribute to medical waste. Growing environmental concerns and regulatory restrictions on single-use plastics can hinder market growth.

2. Cost Sensitivity in Low-Income Regions:

The higher cost of disposables compared to reusable counterparts may restrict adoption in price-sensitive markets, particularly in underfunded healthcare systems in low- and middle-income countries.

Opportunity:

1. Biodegradable Material Development:

The emergence of eco-friendly and biodegradable materials for disposable medical devices provides growth opportunities, aligning with global sustainability goals.

2. Technological Integration for Enhanced Safety:

Innovations such as color-coded and ENFit-compatible syringes to avoid misconnections and improve dosage accuracy are driving demand from safety-conscious institutions.

Market by System Type Insights:

Based on system type, ENFit enteral syringes led the market in 2023 due to enhanced safety and reduced misconnections. With global initiatives like ISO 80369 promoting standardization in enteral devices, the ENFit segment is expected to retain dominance throughout the forecast period.

Market by End-use Insights:

By end use, the hospitals segment accounted for the largest revenue share in 2023. Hospitals rely heavily on enteral syringes in critical care and neonatal units. However, the home care segment is expected to register the fastest growth due to the increased preference for home-based nutritional support, especially for geriatric and post-operative patients.

Market by Regional Insights:

North America held the dominant share of the Disposable Enteral Syringes Market in 2023, attributed to its advanced healthcare infrastructure, high neonatal care spending, and strong regulatory enforcement. Meanwhile, the Asia-Pacific region is expected to witness the highest growth rate, driven by expanding healthcare access, rising birth rates, and growing awareness of patient safety protocols in countries like India and China.

Competitive Scenario:

Key players in the global disposable enteral syringes market include BD (Becton, Dickinson and Company), Cardinal Health, Medtronic plc, Baxter International Inc., Terumo Corporation, Vygon Group, Amsino International Inc., and GBUK Enteral Ltd. These companies are engaged in strategic partnerships, product launches, and geographic expansion to maintain competitive advantage.

Key Market Developments:

In 2023, BD introduced a range of color-coded ENFit-compatible disposable enteral syringes designed to reduce misconnections in neonatal care.

In 2024, Cardinal Health partnered with a major pediatric hospital chain in North America to supply standardized enteral nutrition tools, including disposable syringes.

In 2025, Vygon Group launched biodegradable enteral syringes aimed at meeting environmental sustainability targets in European healthcare institutions.

Scope of Work – Global Disposable Enteral Syringes Market

Report Metric Details

Market Size (2023) USD 0.74 billion

Projected Market Size (2031) USD 1.31 billion

CAGR (2023–2031) 7.3%

Market Segments System Type (ENFit, Non-ENFit), End-use (Hospitals, Home Care, Others), Region

Growth Drivers Rise in chronic illness and preterm births, increasing home healthcare, infection control awareness

Opportunities Biodegradable syringes, technological innovations (e.g., color coding, ENFit compatibility)

FAQs:

1) What is the current market size of the Global Disposable Enteral Syringes Market?

The market size was valued at USD 0.74 billion in 2023.

2) What is the major growth driver of the Global Disposable Enteral Syringes Market?

The key growth driver is the rising prevalence of chronic diseases and preterm births, increasing the need for enteral nutrition solutions.

3) Which is the largest region during the forecast period in the Global Disposable Enteral Syringes Market?

North America is expected to remain the leading region, owing to its advanced healthcare systems and neonatal care practices.

4) Which segment accounted for the largest market share in the Global Disposable Enteral Syringes Market?

The ENFit system type segment led the market in 2023 due to global safety initiatives.

5) Who are the key market players in the Global Disposable Enteral Syringes Market?

Key players include BD, Cardinal Health, Medtronic plc, Terumo Corporation, Baxter International, and Vygon Group.